Patents by Inventor Eric Bennett

Eric Bennett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240070202
    Abstract: A computer-implemented technique is described herein for assisting a user in advancing a task objective. The technique uses a suggestion-generating system (SGS) to provide one or more suggestions to a user in response to at least a last-submitted query provided by the user. The SGS may correspond to a classification-type or generative-type neural network. The SGS uses a machine-trained model that is trained using a multi-task training framework based on plural groups of training examples, which, in turn, are produced using different respective example-generating methods. One such example-generating method constructs a training example from queries in a search session. It operates by identifying the task-related intent the queries, and then identifying at least one sequence of queries in the search session that exhibits a coherent task-related intent. A training example is constructed based on queries in such a sequence.
    Type: Application
    Filed: November 7, 2023
    Publication date: February 29, 2024
    Applicant: Microsoft Technology Licensing, LLC
    Inventors: Corby Louis ROSSET, Chenyan XIONG, Paul Nathan BENNETT, Saurabh Kumar TIWARY, Daniel Fernando CAMPOS, Xia SONG, Nicholas Eric CRASWELL
  • Publication number: 20230379226
    Abstract: A communication system provides multimedia communications within and between armored ground combat vehicles (GCVs). The system includes client computers within the armored GCVs providing distributed and interconnected multimedia communications among the client computers. The multimedia communication may include a one-to-one communication, a text communication to a group, an audio communication to a group, or a video communication to a group. Logic providing the distributed and interconnected multimedia communications is not located at a single client computer. The client computers display graphical user interfaces (GUIs) enabling soldiers to select parameters of the communication system with some GUIs providing presence discovery among the armored GCVs. One of the plurality of client computers acts as an origination station and other client computers may be configured as receiving communication station(s).
    Type: Application
    Filed: February 6, 2023
    Publication date: November 23, 2023
    Applicant: GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY
    Inventors: Olatunde O. Bamgboye, Eric Bennett
  • Patent number: 11575585
    Abstract: A communication system provides multimedia communications within and between armored ground combat vehicles (GCVs). The system includes client computers within the armored GCVs providing distributed and interconnected multimedia communications among the client computers. The multimedia communication may include a one-to-one communication, a text communication to a group, an audio communication to a group, or a video communication to a group. Logic providing the distributed and interconnected multimedia communications is not located at a single client computer. The client computers display graphical user interfaces (GUIs) enabling soldiers to select parameters of the communication system with some GUIs providing presence discovery among the armored GCVs. One of the plurality of client computers acts as an origination station and other client computers may be configured as receiving communication station(s).
    Type: Grant
    Filed: September 25, 2019
    Date of Patent: February 7, 2023
    Assignee: Government of the United States, as represented by the Secretary of the Army
    Inventors: Olatunde O. Bamgboye, Eric Bennett
  • Publication number: 20220074075
    Abstract: According to an embodiment of the disclosure, a method of creating an object with a conduit is disclosed. A material is deposited on a sacrificial collector; and, the sacrificial collector is then removed to create the object with the conduit. Both the object and the sacrificial collector can approximate the shape of desired blood vessel. The method can also include a 3-D printing of the desired shape of the mold and utilization of Gallium as the sacrificial collector. The sacrificial object is created by insertion of the gallium in the mold. After removal of the gallium from the mold, fibers are electrospun onto the gallium. The gallium is removed through melting—leaving a scaffold, the object with the conduit. In addition to the gallium, an extra sacrificial layer of a water-soluble material may be utilized.
    Type: Application
    Filed: September 6, 2021
    Publication date: March 10, 2022
    Applicant: Frontier Bio Corporation
    Inventor: Eric Bennett
  • Publication number: 20220032028
    Abstract: A device can include a capsule containing an array of microneedles and a mechanical actuator. The device can be in an ingestible form for delivery to a duodenum or other target location within a subject and can release the mechanical actuator from constraint by the capsule in response to stimuli or conditions in or en route to the duodenum or other target location. The mechanical actuator upon release from constraint by the capsule can expand outwardly (e.g., responsive to a bias provided by a flexibly resilient material of the mechanical actuator) in a direction away from a central longitudinal axis of the mechanical actuator and drive the array of microneedles into penetrating engagement with a lining of the duodenum or other target location. The penetrating engagement can facilitate delivery of a biotherapeutic agent or other payload via the microneedles.
    Type: Application
    Filed: July 21, 2021
    Publication date: February 3, 2022
    Applicant: Verily Life Sciences LLC
    Inventors: Eric Bennett, Kimberly Kam, Martin Sheridan, Annapurna Karicherla, Kassidy MacPhail
  • Patent number: 11229749
    Abstract: A dosage measurement system is adapted to receive a motion from a dosage injection mechanism disposed within a drug injection pen. The dosage measurement system includes a substrate, a sensing capacitor disposed on the substrate, and a lifting tab. The sensing capacitor includes a dielectric layer disposed between a base plate and an adjustable plate. The lifting tab is attached to the adjustable plate and positioned to engage an undulation pattern disposed on a component attached to the dosage injection mechanism. The lifting tab is adapted to physically change a separation distance between the adjustable plate and the base plate in a reciprocal manner in response to the motion of the dosage injection mechanism and engagement with the undulation pattern. A capacitance of the sensing capacitor changes in response to the engagement of the lifting tab with the undulation pattern and the motion of the dosage injection mechanism.
    Type: Grant
    Filed: September 3, 2019
    Date of Patent: January 25, 2022
    Assignee: Verily Life Sciences LLC
    Inventors: William Biederman, Louis Jung, Sean Frick, Benjamin Collins, Eric Bennett
  • Patent number: 11147852
    Abstract: The present invention is directed to antibodies, and antigen-binding portions thereof, engineered to introduce amino acids for site-specific conjugation. The invention relates to engineered antibody constant region (Fc, C?, C?, and C?) polypeptides, and portions thereof, and antibodies comprising the polypeptides. Further, the invention relates to Fc fusion proteins comprising an engineered Fc region. The invention also relates to methods and uses of the engineered antibodies and portions for, among other things, production of antibody-drug conjugate therapeutics.
    Type: Grant
    Filed: December 19, 2012
    Date of Patent: October 19, 2021
    Assignee: Pfizer Inc.
    Inventors: Kimberly Marquette, Eric Bennett, Lioudmila Tchistiakova, L. Nathan Tumey, Jack Bikker, Valerie Calabro, Edmund Graziani
  • Publication number: 20210102223
    Abstract: The present invention relates to a mammalian cell comprising a gene encoding a polypeptide of interest, wherein the polypeptide of interest is expressed comprising one or more posttranslational modification patterns. These modifications are useful for example in glycoprotein production where the antibodies with the modifications have an enhanced antibody-dependent cell-mediated cytotoxicity (ADCC). The present invention also relates to methods for producing the glycoproteins and compositions comprising the glycoproteins, and their uses.
    Type: Application
    Filed: November 5, 2020
    Publication date: April 8, 2021
    Inventors: Henrik Clausen, Zhang Yang, Adnan Fevzi Halim, Eric Bennett, Carsten Behrens, Malene Bech Vester-Christensen, Shamim Herbert Rahman
  • Publication number: 20210095317
    Abstract: The present invention relates to a mammalian cell comprising a gene encoding a polypeptide of interest, wherein the polypeptide of interest is expressed comprising one or more posttranslational modification patterns. These modifications are useful for example in glycoprotein production where the antibodies with the modifications have an enhanced antibody-dependent cell-mediated cytotoxicity (ADCC). The present invention also relates to methods for producing the glycoproteins and compositions comprising the glycoproteins, and their uses.
    Type: Application
    Filed: November 5, 2020
    Publication date: April 1, 2021
    Inventors: Henrik Clausen, Zhang Yang, Adnan Fevzi Halim, Eric Bennett, Carsten Behrens, Malene Bech Vester-Christensen, Shamim Herbert Rahman
  • Publication number: 20210087587
    Abstract: The present invention relates to a mammalian cell comprising a gene encoding a polypeptide of interest, wherein the polypeptide of interest is expressed comprising one or more posttranslational modification patterns. These modifications are useful for example in glycoprotein production where the antibodies with the modifications have an enhanced antibody-dependent cell-mediated cytotoxicity (ADCC). The present invention also relates to methods for producing the glycoproteins and compositions comprising the glycoproteins, and their uses.
    Type: Application
    Filed: November 5, 2020
    Publication date: March 25, 2021
    Inventors: Henrik Clausen, Zhang Yang, Adnan Fevzi Halim, Eric Bennett, Carsten Behrens, Malene Bech Vester-Christensen, Shamim Herbert Rahman
  • Patent number: 10889845
    Abstract: The present invention relates to a cell comprising a gene encoding a polypeptide of interest, wherein the polypeptide of interest is expressed comprising one or more posttranslational modification patterns. These modifications are useful for example in improvement of pharmacokinetic properties, i.e. by attaching PEG chains to proteins. The present invention also relates to methods for producing the antibodies and compositions comprising the antibodies, and their uses.
    Type: Grant
    Filed: June 15, 2016
    Date of Patent: January 12, 2021
    Assignees: UNIVERSITY OF COPENHAGEN, DANMARKS TEKNISKE UNIVERSITET
    Inventors: Shamim Herbert Rahman, Carsten Behrens, Malene Bech Vester-Christensen, Henrik Clausen, Zhang Yang, Adnan Fevzi Halim, Eric Bennett
  • Publication number: 20200406542
    Abstract: According to an embodiment of the disclosure, a device with the capability of performing both conventional bioprinting and electrohydrodynamic printing (EHDP) is provided. The disclosure also provides methods of using the described device, methods of optimization of printing parameters, methods of position calibration, methods of selecting or creating voltage waveforms, and other methods relating to the fabrication device.
    Type: Application
    Filed: September 7, 2020
    Publication date: December 31, 2020
    Applicant: FRONTIER BIO CORPORATION
    Inventor: Eric Bennett
  • Patent number: 10858671
    Abstract: The present invention relates to a mammalian cell comprising a gene encoding a polypeptide of interest, wherein the polypeptide of interest is expressed comprising one or more posttranslational modification patterns. These modifications are useful for example in glycoprotein production where the antibodies with the modifications have an enhanced antibody-dependent cell-mediated cytotoxicity (ADCC). The present invention also relates to methods for producing the glycoproteins and compositions comprising the glycoproteins, and their uses.
    Type: Grant
    Filed: December 11, 2015
    Date of Patent: December 8, 2020
    Assignees: University of Copenhagen, Dansmarks Tekniske Universitet
    Inventors: Henrik Clausen, Zhang Yang, Adnan Fevzi Halim, Eric Bennett, Carsten Behrens, Malene Bech Vester-Christensen, Shamim Herbert Rahman
  • Patent number: 10599300
    Abstract: A method and apparatus is provided for operating a mobile device having stored thereon a plurality of applications (“apps”) that are each configured to capture an image. The method includes receiving first user input data requesting invocation of a given one of the applications. The given application is launched by the user. After launching the given application a user interface is presented which serves as an entry point through which all of the image capture applications stored on the mobile device are made available to the user.
    Type: Grant
    Filed: August 9, 2016
    Date of Patent: March 24, 2020
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Aaron Sauve, Shamik Bandyopadhyay, Kathryn C. Lemson, Jannes Paul Peters, Eric Bennett, Ahmad Bilal
  • Publication number: 20200078527
    Abstract: A dosage measurement system is adapted to receive a motion from a dosage injection mechanism disposed within a drug injection pen. The dosage measurement system includes a substrate, a sensing capacitor disposed on the substrate, and a lifting tab. The sensing capacitor includes a dielectric layer disposed between a base plate and an adjustable plate. The lifting tab is attached to the adjustable plate and positioned to engage an undulation pattern disposed on a component attached to the dosage injection mechanism. The lifting tab is adapted to physically change a separation distance between the adjustable plate and the base plate in a reciprocal manner in response to the motion of the dosage injection mechanism and engagement with the undulation pattern. A capacitance of the sensing capacitor changes in response to the engagement of the lifting tab with the undulation pattern and the motion of the dosage injection mechanism.
    Type: Application
    Filed: September 3, 2019
    Publication date: March 12, 2020
    Inventors: William Biederman, Louis Jung, Sean Frick, Benjamin Collins, Eric Bennett
  • Publication number: 20190330601
    Abstract: The present invention relates to a method for display of a plurality of mammalian glycans on cells or proteins for probing biological interactions and identifying glycan structures involved. A plurality of mammalian cells is genetically engineered in a combinatorial approach to differentially express the human glycome. Genetic engineering of the cell produces a plurality isogenic cells with different repertoires of glycosyltransferases and display of glycans that is used to interpret biological interactions. The plurality of engineered cells display glycans with and without the context of specific proteins exogeneously expressed, and is useful for detection and optimization of biological interactions for example binding of lectins, antibodies, viruses and bacteria and glycoproteins.
    Type: Application
    Filed: May 11, 2017
    Publication date: October 31, 2019
    Inventors: Eric BENNETT, Yoshiki NARIMATSU, Catharina STEENTOFT, Zhang YANG, Ulla MANDEL, Henrik CLAUSEN
  • Publication number: 20190203247
    Abstract: The present invention relates to a cell comprising a gene encoding a polypeptide of interest, wherein the polypeptide of interest is expressed comprising one or more posttranslational modification patterns. These modifications are useful for example in improvement of pharmacokinetic properties, i.e. by attaching PEG chains to proteins. The present invention also relates to methods for producing the antibodies and compositions comprising the antibodies, and their uses.
    Type: Application
    Filed: June 15, 2016
    Publication date: July 4, 2019
    Inventors: Shamim Herbert RAHMAN, Carsten BEHRENS, Malene Bech VESTER-CHRISTENSEN, Henrik CLAUSEN, Yang ZHANG, Adnan Fevzi HALIM, Eric BENNETT
  • Patent number: 10299947
    Abstract: A system for mechanically deploying intraluminal implants is disclosed. The system is used with an implant that is delivered and/or deployed via a pull wire and includes a handle having a funnel and receiving channel for receiving the pull wire, a slider having a thumb grip and a wedge, and a shuttle having a grabber for grasping the pull wire. The thumb grip is pulled proximally to retract the wedge to cause the grabber to grasp the wire and retract the shuttle but not the wire. An extension spring linked between the slider and the shuttle abruptly pulls the shuttle to retract the pull wire after the slider is fully retracted.
    Type: Grant
    Filed: March 6, 2017
    Date of Patent: May 28, 2019
    Assignee: Penumbra, Inc.
    Inventors: Eric Bennett, Erin Vitus, Matt Vargas, Arani Bose, Stephen Pons, Ben Tompkins, David Barry
  • Publication number: 20170367857
    Abstract: A system for mechanically deploying intraluminal implants is disclosed. The system is used with an implant that is delivered and/or deployed via a pull wire and includes a handle having a funnel and receiving channel for receiving the pull wire, a slider having a thumb grip and a wedge, and a shuttle having a grabber for grasping the pull wire. The thumb grip is pulled proximally to retract the wedge to cause the grabber to grasp the wire and retract the shuttle but not the wire. An extension spring linked between the slider and the shuttle abruptly pulls the shuttle to retract the pull wire after the slider is fully retracted.
    Type: Application
    Filed: March 6, 2017
    Publication date: December 28, 2017
    Applicant: Penumbra Inc.
    Inventors: Eric Bennett, Erin Vitus, Matt Vargas, Arani Bose, Stephen Pons, Ben Tompkins, David Barry
  • Publication number: 20170369905
    Abstract: The present invention relates to a mammalian cell comprising a gene encoding a polypeptide of interest, wherein the polypeptide of interest is expressed comprising one or more posttranslational modification patterns. These modifications are useful for example in glycoprotein production where the antibodies with the modifications have an enhanced antibody-dependent cell-mediated cytotoxicity (ADCC). The present invention also relates to methods for producing the glycoproteins and compositions comprising the glycoproteins, and their uses.
    Type: Application
    Filed: December 11, 2015
    Publication date: December 28, 2017
    Inventors: Henrik Clausen, Zhang Yang, Adnan Fevzi Halim, Eric Bennett, Carsten Behrens, Malene Bech Vester-Christensen, Shamim Herbert Rahman